Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand

The positive predictive value of newborn screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency was <2% in New Zealand. This is despite a bloodspot second-tier immunoassay method for 17-hydroxyprogesterone measurement with an additional solvent extract step to reduce the nu...

Descripción completa

Detalles Bibliográficos
Autores principales: de Hora, Mark R., Heather, Natasha L., Patel, Tejal, Bresnahan, Lauren G., Webster, Dianne, Hofman, Paul L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422986/
https://www.ncbi.nlm.nih.gov/pubmed/33073005
http://dx.doi.org/10.3390/ijns6010006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422986/
https://www.ncbi.nlm.nih.gov/pubmed/33073005
http://dx.doi.org/10.3390/ijns6010006

Ejemplares similares